HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Ivabradine Hydrochloride

HCID 3045381
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
148849-67-6
Standard SMILES
COc1cc2c(cc1OC)CC(=O)N(CCCN(C)C[C@H]1Cc3cc(OC)c(OC)cc31)CC2.Cl
InChIKey
HLUKNZUABFFNQS-ZMBIFBSDSA-N
Molecular formula
C27H37ClN2O5
Average molar mass
505 g/mol
Monoisotopic mass
504.23909996

Overview

Ivabradine hydrochloride is a hydrochloride obtained by combining ivabradine with one molar equivalent of hydrochloric acid. Used to treat patients with angina who have intolerance to beta blockers and/or heart failure. It has a role as a cardiotonic drug. It contains an ivabradine(1+).

Names & identifiers

Preferred name
Ivabradine Hydrochloride
IUPAC
3-[3-[[(7S)-3,4-dimethoxy-7-bicyclo[4.2.0]octa-1,3,5-trienyl]methyl-methylamino]propyl]-7,8-dimethoxy-2,5-dihydro-1H-3-benzazepin-4-one;hydrochloride
English name
Ivabradine hydrochloride
Molecular formula
C27H37ClN2O5
Molecular weight
505.05

Names & synonyms

Ivabradine hydrochloride148849-67-6Ivabradine HClCoralanIvabrandine hydrochlorideDTXSID2046913AMG 998ivabradine monohydrochlorideUNII-TP19837BZKTP19837BZK2H-3-Benzazepin-2-one, 3-[3-[[[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]methylamino]propyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-, hydrochloride (1:1)AMG-998
Show more names
ProcoralanIvabradine hydrochloridCS-774S-16257CorlentorS 16257-2C27H37ClN2O5D6-Ivabradine HCl2H-3-Benzazepin-2-on
DTXCID0026913CHEBI:85969(7,8-Dimethoxy 3-(3-(((1S)-(4,5-dimethoxybenzocyclobutan-1-yl)methyl)methylamino)propyl)-1,3,4,5-tetrahydro-2H-benzazepin-2-one hydrochloride2H-3-BENZAZEPIN-2-ONE, 3-(3-((((7S)-3,4-DIMETHOXYBICYCLO(4.2.0)OCTA-1,3,5-TRIEN-7-YL)METHYL)METHYLAMINO)PROPYL)-1,3,4,5-TETRAHYDRO-7,8-DIMETHOXY-, HYDROCHLORIDE (1:1)2H-3-Benzazepin-2-one, 3-(3-((((7S)-3,4-dimethoxybicyclo(4.2.0)octa-1,3,5-trien-7-yl)methyl)methylamino)propyl)-1,3,4,5-tetrahydro-7,8-dimethoxy-, monohydrochloride2H-3-Benzazepin-2-one, 3-(3-(((3,4-dimethoxybicyclo(4.2.0)octa-1,3,5-trien-7-yl)methyl)methylamino)propyl)-1,3,4,5-tetrahydro-7,8-dimethoxy-, monohydrochloride, (S)-3-{3-[{[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl}(methyl)amino]propyl}-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one--hydrogen chloride (1/1)3-(3-((((7S)-3,4-dimethoxybicyclo(4.2.0)octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one--hydrogen chloride (1/1)

Properties

Computed structural properties

Topological polar surface area
60.5 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
6
Rotatable bonds
10
Heavy atoms
35
Formal charge
0
Complexity
663

Experimental & physicochemical properties

Human Drugs · 6 items

FDA approved drugs -> Active ingredient

EMA approved medicines: Human medicine

EMA approved medicines: Human medicine

EMA approved medicines: Human medicine

EMA approved medicines: Human medicine

FDA approved drugs -> Active ingredient

Physicochemical properties

Melting point
193 · 193-196C
alpha
58921 · 58921 +7.8°; 36521 +27.8° (c = 1% in DMSO)
storage temp.
2 · 2-8°C
solubility
2 O: · H2O: ≥5mg/mL (warmed)
form
powder
color
white to beige
optical activity
5 to · [α]/D +5 to +9°, c = 1 in DMSO
Water Solubility
2 O: · H2O: ≥5mg/mL (warmed)
Merck
14 · 14,5247
InChIKey
HLUKNZUABFFNQS-ZMBIFBSDSA-N
SMILES
C([C@H]1CC2=CC(OC)=C(OC)C=C12)N(C)CCCN1CCC2=CC(OC)=C(OC)C=C2CC1=O.Cl |&1:1,r|

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H302 (14.6%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P260, P264, P270, P273, P280, P301+P317, P318, P319, P330, P391, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 48 reports by companies from 9 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Hazard Classes and CategoriesAcute Tox. 4 (14.6%)

Toxicology

Drug Induced Liver Injury · 6 items

Drug Induced Liver Injury Rank (DILIrank 2.0)

Ivabradine hydrochloride

vNo-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

Safety data

wgk
3
ridadr
UN 3077 9 / PGIII
hs_code
2933.79.1500
risk_code
50/53
Signal word
Warning
Symbol(GHS)
GHS09
hazard_code
N
safety_code
60-61
Storage Class
11 - Combustible Solids
Hazard statements
H400

Chemistry & industry

Applications · 5 items

DescriptionIn an effort to develop angina agents without the unwanted negative inotropic and hypotensive effects associated with b-adrenergic blockers and calcium channel blockers, a new class of heart-rate reducing compounds that act specifically on the sinoatrial (SA) node has been explored. These bradycardic agents interact directly with the pacemaking cell of the SA node and the hyperpolarization- activated If , the primary pacemaking current. Ivabradine has evolved as a specific inhibitor of If current through its contact with f-channels on the intracellular side of the plasma membrane. As a consequence, ivabradine reduces the speed of diastolic depolarization and decreases heart rate. It has been approved for the treatment of chronic stable angina and provides a viable alternative to patients with a contraindication or intolerance of b-blockers. Evaluation is also underway for the potential treatment of ischemic heart disease. Using a patch-clamp technique on rabbit sinoatrial node cells, inhibition of If current ranged from 6% (0.03 mM) – 80% (10 mM). .

UsesIvabradine hydrochloride has been used as a potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel (HCN)2 blocker in embryoid body (EB) and rat engineered heart tissue (EHT).

UsesIvabradine HCl, a new If inhibitor with IC 50 of 2.9 μM which acts specifically on the pacemaker activity of the sinoatrial node, is a pure heart rate lowering agent

Usesangina therapeutic

UsesSelective bradycardic agent with direct effect on the pacemaker If current of the sinoatrial node. Antianginal

Upstream & downstream products

Upstream raw materials

3-[3-({[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl}(methyl)amino)propyl]-7,8-dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one hydrochloride

Related reactions

7 records
New reaction record
HRID 423133 reaction equation
HRID 423133As product
HRID 423135 reaction equation
HRID 423135As product
HRID 625924 reaction equation
HRID 625924As product
HRID 1048837 reaction equation
HRID 1048837As product
HRID 1510817 reaction equation
HRID 1510817As product
HRID 1510820 reaction equation
HRID 1510820As reactant
HRID 2271382 reaction equation
HRID 2271382As product

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
148849-67-6
PubChem CID
3045381
DTXSID
DTXSID2046913
ChEMBL
CHEMBL2145077
ChEBI
CHEBI:85969
UNII
TP19837BZK
EC Number
638-798-3
CAS DataBase Reference
148849 · 148849-67-6(CAS DataBase Reference)
FDA UNII
19837 BZK · TP19837BZK
NCI Drug Dictionary
ivabradine hydrochloride
UNSPSC Code
12352200 · 12352200
NACRES
77 · NA.77
Protein binding
70 % · 70%
Excreted unchanged in urine
4 % · 4%
Volume of distribution
100 Litres · 100 Litres
Biological half-life
2 · 2 / Unchanged
Symbol(GHS)
9 · GHS09
Signal word
Warning
Hazard statements
400 · H400
Precautionary statements
273 · P273
Hazard Codes
N
Risk Statements
50 · 50/53
Safety Statements
60 · 60-61
RIDADR
3077 · UN 3077 9 / PGIII
WGK Germany
3 · 3
HS Code
2933.79 · 2933.79.1500
Storage Class
11 · 11 - Combustible Solids
Hazard Classifications
1 · Aquatic Acute 1
Hazard Classifications
Aquatic Acute 1
Precautionary statements
P273
3-[3-[[[(7S)-3,4-DiMethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]Methyl]MethylaMino]propyl]-1,3-dihydro-7,8-diMethoxy-H-3-benzazepin-2-one
(1S)-4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutane hydrochloride
Ivabradine
Ethyl acetate
Isopropyl alcohol
Hydrochloric acid

Additional notes

DefinitionChEBI: A hydrochloride obtained by combining ivabradine with one molar equivalent of hydrochloric acid. Used to treat patients with angina who have intolerance to beta blockers and/or heart failure.